×
News Home

Is Arcturus Therapeutics Holdings Inc (ARCT) a Good Buy in the Biotechnology Industry?

Thursday, November 18, 2021 10:45 AM | InvestorsObserver Analysts
Is Arcturus Therapeutics Holdings Inc (ARCT) a Good Buy in the Biotechnology Industry?

Arcturus Therapeutics Holdings Inc (ARCT) is near the top in its industry group according to InvestorsObserver. ARCT gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Arcturus Therapeutics Holdings Inc gets a 89 rank in the Biotechnology industry. Biotechnology is number 85 out of 148 industries.

Overall Score - 61
ARCT has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on ARCT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?

Arcturus Therapeutics Holdings Inc (ARCT) stock has risen 0.82% while the S&P 500 has fallen -0.27% as of 10:44 AM on Thursday, Nov 18. ARCT is up $0.30 from the previous closing price of $36.65 on volume of 92,095 shares. Over the past year the S&P 500 has risen 31.07% while ARCT has fallen -34.42%. ARCT lost -$7.52 per share the over the last 12 months. Click Here to get the full Stock Report for Arcturus Therapeutics Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App